# ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate

> **NCT01984268** · PHASE2 · TERMINATED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 15 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** ACTHAR

## Key facts

- **NCT ID:** NCT01984268
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06-23
- **Primary completion:** 2016-09-01
- **Final completion:** 2016-09-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01984268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01984268, "ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01984268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*